WO2024129048A1 - Composition synergique - Google Patents
Composition synergique Download PDFInfo
- Publication number
- WO2024129048A1 WO2024129048A1 PCT/TR2023/051557 TR2023051557W WO2024129048A1 WO 2024129048 A1 WO2024129048 A1 WO 2024129048A1 TR 2023051557 W TR2023051557 W TR 2023051557W WO 2024129048 A1 WO2024129048 A1 WO 2024129048A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- extract
- bone marrow
- total weight
- burns
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 230000002195 synergetic effect Effects 0.000 title description 5
- 244000141009 Hypericum perforatum Species 0.000 claims abstract description 82
- 235000017309 Hypericum perforatum Nutrition 0.000 claims abstract description 72
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 50
- 239000000284 extract Substances 0.000 claims abstract description 34
- 206010052428 Wound Diseases 0.000 claims abstract description 33
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 33
- 230000035876 healing Effects 0.000 claims abstract description 18
- 239000003921 oil Substances 0.000 claims description 141
- 235000019198 oils Nutrition 0.000 claims description 141
- 238000000034 method Methods 0.000 claims description 66
- 235000008390 olive oil Nutrition 0.000 claims description 41
- 239000004006 olive oil Substances 0.000 claims description 41
- 238000002803 maceration Methods 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 22
- 239000002775 capsule Substances 0.000 claims description 18
- 239000010774 macerated oil Substances 0.000 claims description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 14
- 208000025865 Ulcer Diseases 0.000 claims description 14
- 231100000397 ulcer Toxicity 0.000 claims description 14
- 239000008158 vegetable oil Substances 0.000 claims description 14
- 230000000699 topical effect Effects 0.000 claims description 12
- 235000019486 Sunflower oil Nutrition 0.000 claims description 7
- 239000002600 sunflower oil Substances 0.000 claims description 7
- 244000144725 Amygdalus communis Species 0.000 claims description 6
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 6
- 235000019485 Safflower oil Nutrition 0.000 claims description 6
- 235000019498 Walnut oil Nutrition 0.000 claims description 6
- 239000008168 almond oil Substances 0.000 claims description 6
- 239000000828 canola oil Substances 0.000 claims description 6
- 235000019519 canola oil Nutrition 0.000 claims description 6
- 239000000944 linseed oil Substances 0.000 claims description 6
- 235000021388 linseed oil Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000005713 safflower oil Nutrition 0.000 claims description 6
- 239000003813 safflower oil Substances 0.000 claims description 6
- 239000008159 sesame oil Substances 0.000 claims description 6
- 235000011803 sesame oil Nutrition 0.000 claims description 6
- 239000008170 walnut oil Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000007781 pre-processing Methods 0.000 claims description 3
- 230000003902 lesion Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 244000309466 calf Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 3
- 229940005608 hypericin Drugs 0.000 description 3
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- YLNDNABNWASMFD-UHFFFAOYSA-N 4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=[N+](C)C=CN1C YLNDNABNWASMFD-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- YXBUQQDFTYOHQI-UHFFFAOYSA-N Pseudohypericin Chemical compound OC1=CC(O)=C2C(=O)C3=C(O)C=C(C)C4=C3C3=C2C1=C(C(O)=CC(O)=C1C2=O)C1=C3C1=C2C(O)=CC(CO)=C14 YXBUQQDFTYOHQI-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- YLILOANQCQKPOD-UHFFFAOYSA-N protohypericin Chemical compound C12=C(O)C=C(O)C(C(C3=C(O)C=C(C=C33)C)=O)=C2C3=C2C3=C1C(O)=CC(O)=C3C(=O)C1=C(O)C=C(C)C=C12 YLILOANQCQKPOD-UHFFFAOYSA-N 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- GEHPRJRWZDWFBJ-FOCLMDBBSA-N (2E)-2-heptadecenoic acid Chemical compound CCCCCCCCCCCCCC\C=C\C(O)=O GEHPRJRWZDWFBJ-FOCLMDBBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- SUOQGZCCNGMYHT-WYSBIKLGSA-N Furohyperforin Chemical compound O=C1C(CC=C(C)C)=C2O[C@H](C(C)(C)O)C[C@@]22C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O SUOQGZCCNGMYHT-WYSBIKLGSA-N 0.000 description 1
- FBBDPYYKVMTRAB-WHSGKLGMSA-N Furohyperforin Natural products O=C([C@H](CC)C)[C@@]12[C@@](CC/C=C(\C)/C)(C)[C@@H](C/C=C(\C)/C)C[C@@]3(C1=O)C(=C(C/C=C(\C)/C)C2=O)O[C@H](C(O)(C)C)C3 FBBDPYYKVMTRAB-WHSGKLGMSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- MGKCAFQXBAFOSW-ACJQSPJVSA-N O=C1C(CC=C(C)C)=C(O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)CC)C2=O Chemical compound O=C1C(CC=C(C)C)=C(O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)CC)C2=O MGKCAFQXBAFOSW-ACJQSPJVSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241001377938 Yara Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- RIISSLSXWPTKFE-UHFFFAOYSA-N adhyperforin Natural products CCC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O RIISSLSXWPTKFE-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- -1 and Omega 3 and 6 Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010462 extra virgin olive oil Substances 0.000 description 1
- 235000021010 extra-virgin olive oil Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 1
- IWBJJCOKGLUQIZ-HQKKAZOISA-N hyperforin Chemical compound OC1=C(CC=C(C)C)C(=O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O IWBJJCOKGLUQIZ-HQKKAZOISA-N 0.000 description 1
- QOVWXXKVLJOKNW-UHFFFAOYSA-N hyperforin Natural products CC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O QOVWXXKVLJOKNW-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002018 neem oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000002444 phloroglucinyl group Chemical class [H]OC1=C([H])C(O[H])=C(*)C(O[H])=C1[H] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Definitions
- the invention relates to natural compositions of plant origin for use in the treatment and healing of external lesions such as wounds and bums.
- the invention particularly relates to compositions containing St. John’s Wort oil for use in the treatment and healing of external lesions such as wounds and burns.
- Hypericum perforatum St. John’s Wort or Klamath weed
- St. John’s Wort is a flowering plant that is approximately 30-100 cm in height.
- researchers are numerous studies on the history, ethnob otani cal use, chemical composition and activities of St. John’s Wort, also known in Anatolia by the names such as kiln?
- St. John’s Wort oil contains hyperforin, adhyperforin and furohyperforin, which are derivatives of phloroglucinol. It is thought that from naphthodianthrones, protohypericin and pseudoprotohypericin transform into more stable hypericin and pseudohypericin (Al- tan et al., 2015). Through numerous pharmacological studies, it has been proven that these substances contained in H. perforatum exhibit anti-inflammatory and antimicrobial effects. Alongside these effects, macerated oil has been used for centuries in the treatment of wounds and burns. In addition to these effects, the plants and their extracts used in the treatment of depression also have anticancer, antioxidant, antitumoral, and antiviral effects (Schempp et al., 2002).
- the oil obtained through maceration from St. John's Wort (“St. John's Wort oil” for short) is a product used for various purposes in the field of health as it contains a high concentration of beneficial ingredients. Particularly the macerate prepared with olive oil is highly popular both in our country and worldwide as a wound healing remedy. In oil maceration, the flowering tops of the H. perforatum plant are traditionally left in glass containers filled with olive oil exposed directly to sunlight for 15-45 days.
- the effective compounds of the obtained macerated oil, its stability, composition varying based on the method and oil used, and its characteristic ruby-red color continue to be subjects of ongoing search.
- St. John's Wort oil is also effective in maintaining skin health.
- St. John's Wort oil supports and accelerates cell regeneration, helping to delay signs of aging, prevent wrinkles, and increase skin elasticity. It contributes to achieving the necessary moisture balance for the skin, resulting in a smoother and more vibrant appearance.
- Another significant effect of St. John's Wort oil on the skin is that it eliminates blemishes. Thanks to this effect, regular use of St. John’s Wort oil can reduce scars, burns, and acne marks on the face or body. In areas where the skin tone locally varies or becomes discolored due to factors such as aging, pregnancy, sun exposure, regular application of St. John's Wort oil can even out the skin tone, providing a more pleasant appearance.
- St. John's Wort oil is obtained through the maceration of St. John's Wort flowers in vegetable oils such as olive oil, soybean oil, wheat germ oil, and sunflower oil.
- Turkish patent application no. 2022/014055 relates to an ointment that heals bedsores, first and second degree bums and rashes without leaving scars and the said ointment contains stone-milled cold-pressed olive oil, St. John's Wort oil and paraffin.
- Turkish patent application no. 2022/004749 describes the use of olive oil and St. John's Wort oil in skin infections.
- Turkish patent application no. 2020/17736 describes a herbal analgesic cream containing olive oil with St. John's Wort for use in helping treatment in the health sector and its production method.
- the St. John’s Wort oil is prepared by soaking St. John’s Wort in olive oil for at least three months.
- Turkish patent application no. 2019/10600 relates to a wound dressing developed for use in biomedical/health sector for treatment of chronic wounds including bedsore, diabetic food wounds.
- Said wound dressing comprises St. John’s Wort oil prepared by soaking St. John’s Wort flower in olive oil.
- Turkish patent application no. 2011/02242 describes an ointment formulation which contains the macerate of St. John’s Wort in olive oil.
- Turkish patent application no. 2015/16956 describes a herbal skin cream that contains tetra oil, Klamath weed oil and olive oil.
- Patent document no. RU2736214 describes an ointment to treat wounds.
- Patent document no. EP2185168B2 describes a method to prepare an industrial-scale extract from the flowers and infructescences of H. perforatum in neem oil.
- the present invention relates to compositions that meet the above-mentioned requirements and bring some additional advantages and to methods for preparing these compositions.
- the primary object of the present invention is to provide a composition with natural ingredients, with improved efficacy in the treatment of external wounds and burns, sunburn, abrasions, bruises, ulcers, skin diseases and infected wounds in humans and animals.
- Another object of the present invention is to provide a St. John’s Wort composition with an improved antioxidant, anti-inflammatory, anticancer and/or antimicrobial activity.
- Another object of the present invention is to provide a St. John’s Wort (Hypericum perforatum) composition with an increased amount and strength of its ingredients with antioxidant, anti-inflammatory, anticancer and antimicrobial activities, such as hypericin.
- a further object of the present invention is to provide a composition with an increased treatment and healing effect on wounds and burns compared to the olive oil macerate of St. John’s Wort.
- the present invention provides Hypericum perforatum (St. John’s Wort) extract in oil, said oil comprising a certain ratio of bone marrow oil.
- said oil further comprises a certain ratio of at least one vegetable oil selected from the group including olive oil, sunflower oil, safflower oil, walnut oil, canola oil, flax oil, sesame oil and sweet almond oil.
- said vegetable oil is olive oil.
- said oil comprises bone marrow oil at a ratio of at least 90% by total weight.
- said oil comprises olive oil at a ratio of at most 10% by total weight.
- said oil comprises 90% of bone marrow oil by total weight and 10% of olive oil by total weight.
- the present invention provides use of Hypericum perforatum (St. John’s Wort) extract in oil in the preparation of a medicament for the topical treatment of external wounds, ulcers and burns in humans or animals, wherein said oil comprises a certain ratio of bone marrow oil.
- the present invention provides Hypericum perforatum (St. John’s Wort) extract in oil for use in a method of the topical treatment of external wounds, ulcers and burns in humans or animals, wherein said oil comprises a certain ratio of bone marrow oil.
- the present invention provides a composition comprising Hypericum perforatum extract in oil for use in the topical treatment or healing of external wounds, ulcers and burns in humans or animals, wherein said oil comprises a certain ratio of bone marrow oil.
- the present invention provides a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil, comprising the steps of:
- said oil further comprises a certain ratio of at least one vegetable oil selected from the group including olive oil, sunflower oil, safflower oil, walnut oil, canola oil, flax oil, sesame oil and sweet almond oil.
- said vegetable oil is olive oil.
- said oil comprises bone marrow oil at a ratio of at least 90% by total weight.
- said oil comprises olive oil at a ratio of at most %10 by total weight.
- said oil comprises 90% of bone marrow oil by total weight and 10% of olive oil by total weight.
- the maceration process is carried out at a temperature range of 18-45°C.
- the maceration process is carried out at a temperature range of 25-30°C. In this embodiment, the maceration process is carried out for 3 to 6 weeks, more preferably for 21 to 30 days.
- the maceration process is carried out in a water bath at a temperature range of 40-45°C. In this embodiment, preferably the maceration process is carried out for 1 to 5 hours.
- the said method comprises a step of subjecting Hypericum perforatum flowers and/or capsules to a pre-processing of drying, crushing, mincing, chopping and/or grinding. In a further preferred embodiment of the invention, the said method comprises a step of separating the obtained macerated oil through filtration.
- the present invention provides an extract in oil obtained by a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil, said method comprising the steps of: mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- the present invention provides use of extract in oil obtained by a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil, in the preparation of a medicament for the topical treatment of external wounds, ulcers and burns in humans or animals, said method comprising the steps of: mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil in the preparation of a medicament for the topical treatment of external wounds, ulcers and burns in humans or animals, said method comprising the steps of: mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain
- the present invention provides an extract in oil, obtained by a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil, for use in a method of the topical treatment of external wounds, ulcers and burns in humans or animals, said method comprising the steps of mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil for use in a method of the topical treatment of external wounds, ulcers and burns in humans or animals, said method comprising the steps of mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- the present invention provides an extract in oil obtained by a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil, for use in a topical treatment or healing of external wounds, ulcers and burns in humans or animals, said method comprising the steps of mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- a method for preparing Hypericum perforatum (St. John’s Wort) extract in oil for use in a topical treatment or healing of external wounds, ulcers and burns in humans or animals, said method comprising the steps of mixing a certain amount of Hypericum perforatum flowers and/or capsules with a certain amount of oil, wherein said oil comprises bone marrow oil, and maintaining the obtained mixture to macerate for a certain period of time and at a certain temperature.
- a new composition that has a synergistic effect in the treatment and/or healing of wounds and burns has been invented by the present invention.
- Said composition comprises an extract of Hypericum perforatum (St. John’s Wort) plant in oil.
- Said oil either is bone marrow oil or comprises a certain amount of bone marrow oil. Thanks to the invention, the healing, sedative, antiseptic and antibiotic properties of H. perforatum plant extract are combined with the healing effect of bone marrow oil and it has been found that the obtained product is has a synergistically more effective healing effect on wounds and burns.
- the term “Hypericum perforatum extract in oil” is used in the meaning of a macerated oil obtained by maceration of St. John’ s Wort flowers, capsules (infructescence) or a mixture thereof in oil (the maceration process).
- this term is used in the meaning of a macerated oil (infused oil) into which the active ingredients of St. John’s Wort are extracted.
- St. John’s Wort maceration is carried out in the presence of bone marrow oil.
- the bone marrow oil may be added to the macerated oil obtained through maceration, such as the macerated oil obtained by maceration in olive oil, at a later stage.
- the maceration is carried out in the presence of the bone marrow oil.
- the macerated oil obtained this way has more healing effect.
- the aforementioned oil may further comprise a certain ratio of at least one vegetable oil selected from the group comprising olive oil, sunflower oil, safflower oil, walnut oil, canola oil, flax oil, sesame oil, coconut oil and sweet almond oil.
- said oil comprises at least %90 bone marrow oil by total weight.
- the vegetable oil is preferably olive oil. Due to the combination of bone marrow oil and olive oil, it has been observed that the beneficial effects of olive oil are also incorporated into the composition, yielding that optimal outcomes in the treatment and/or healing of wounds and burns, enhancing the healing effects of the composition.
- said oil contains 90% bone marrow oil by total weight and %10 olive oil by total weight.
- the present invention provide a novel method for preparing H. perforatum extract in oil.
- the flowers and/or capsules (infructescences) of H. perforatum are extracted into bone marrow oil.
- the flowers and/or capsules are harvested at their most mature stage.
- the extraction method applied is the maceration process. It has been found that the composition of the macerated oil obtained through said method has a synergistic therapeutic and/or healing effect in recuperation of wounds and burns. Thanks to the obtained composition, it is possible to rapidly treat and/or heal wounds and burns without the need for the use of adjuvant therapeutic agents such as antibiotics, disinfectants or moisturizers.
- H. perforatum flowers and/or capsules In the method of invention, a certain amount of H. perforatum flowers and/or capsules is put into a glass container.
- H. perforatum flowers and/or capsules can be used as fresh, frozen or lyophilised.
- H. perforatum flowers and/or capsules can be subject to preprocessing of drying, crushing, mincing, chopping and/or grinding.
- a certain amount of an extraction solution containing bone marrow oil is also added to the same container.
- Said extraction solution comprises a) bone marrow oil only or b) bone marrow oil and at least a vegetable oil.
- the extraction solution may further comprise a pharmaceutically acceptable solvent or a solvent mixture.
- said vegetable oil are olive oil, sunflower oil, safflower oil, walnut oil, canola oil, flax oil, sesame oil and sweet almond oil.
- Said vegetable oil is preferably olive oil. It has been found that the effect of the macerated oil prepared with the combination of bone marrow oil and olive oil in the treatment and/or healing of wounds and burns as well as its inflammation-preventive, anti-inflammatory and cell regenerative effects are surprisingly improved compared to macerated oil prepared with only olive oil.
- the extraction solution comprises at least 90% bone marrow oil by total weight.
- the extraction solution (whether macerated oil or infused oil) comprises 90% bone marrow oil based on the total weight and 10% olive oil based on the total weight.
- the weight ratio of said extraction solution to flowers and/or capsules may be between 3-to-l and 15-to-l, depending on the water content of the flowers and/or capsules.
- the obtained mixture is subject to maceration process for a certain period of time and at a certain temperature.
- the maceration process means maintaining H. perforatum flowers and/or capsules in oil for a certain time at a certain temperature for extracting the active ingredients thereof into the oil.
- the maceration process is carried out for 3 to 6 weeks at a temperature of 18-35°C, more preferably at a temperature of 18-30°C.
- the maceration process can be carried out with or without direct sunlight.
- modifications known to the person skilled person in the art can be made to the method of the invention. For instance, the digestion which serves as a faster extraction method in the context of maceration processes may be employed.
- the prepared mixture may undergo digestion at 45°C in a water bath for a duration of 2 hours, as a part of the digestion process. Additionally, agitation of the mixture is also possible throughout the maceration process.
- infused oil takes on its characteristic color, transitioning from amber to orange or ruby red, depending on the solubilization of hypericin in the flowers and/or capsules in oil. Subsequently, the oil is separated from the sediment through filtration and stored in dark-colored glass containers to prevent exposure to light without contact with the air.
- antioxidant, preservative and aromatic essential plant oils such as rosemary oil and basil oil may be added.
- Beeswax may be included as an emulsifier and hardening agent. Olive oil and other seed oils can be added to the composition.
- Bone marrow oil is obtained from the bones of cattle such as calves and/or small animals like sheep, preferably from calf shinbones.
- the bone marrow oil obtained from calf shinbones has higher protein content.
- the bones are cooked in water for a certain period of time.
- the calf shinbones are cooked in drinking water for 35 hours at a temperature below boiling, preferably at 75°C.
- the cooking temperature is reduced after boiling begins and maintained at this temperature.
- the mixture is allowed to rest for a certain period of time. After resting period, the layer of oil that has risen to the top is taken and separated by being passed through a strainer.
- bone marrow oil is obtained.
- the obtained bone marrow oil is in a liquid-solid state at room temperature.
- bone marrow oil is suitable for maceration.
- the liquid phase of the bone marrow oil expands, making it more suitable for maceration.
- the obtained bone marrow oil composition contains fatty acids such as arachidic acid, elaidic acid, gadoleic acid, heptadecenoic acid, linoleic acid, linolenic acid, margaric acid, myristic acid, myristoleic acid, oleic acid, palmitic acid, palmitoleic acid, pentadecanoic acid and stearic acid. Additionally, the bone marrow oil contains calcium, potassium, phosphorus, and magnesium. At the same time, the bone marrow oil is also rich in vitamins A and K, and Omega 3 and 6, as well as iron, zinc and selenium minerals. As it is obtained by boiling for a long duration, the bone marrow oil also contains amino acids found in bone ligaments during the boiling stage.
- fatty acids such as arachidic acid, elaidic acid, gadoleic acid, heptadecenoic acid, linoleic acid, linolenic acid, margaric acid,
- composition obtained by using the method of the invention can be used in the external treatment of wounds, ulcers and burns as an anti-inflammatory drug, antiseptic, and scar reducing agent. Thanks to the synergistic effect of said composition, the therapeutic or healing effect of its natural ingredients is enhanced compared to their individual effects.
- Example 1 Maceration Process Previously harvested St. John’s Wort flowers, each weighing 25 grams, were placed in 3 sealed glass bottles. One of the bottles was filled with bone marrow oil, completely covering the plants. The second bottle was filled with a mixture of olive oil and bone marrow oil in a 1/9 ratio by weight, completely covering the plants. The third bottle was filled with olive oil, completely covering the plants. The ingredients of the mixtures are pro- vided in Table 1.
- the bottles were then placed directly in a sun-exposed area and left for maceration for 45 days. At the end of the 45th day, the samples were filtered and transferred to sealed dark colored tubes, which were then stored in the refrigerator.
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne en particulier des compositions contenant de l'huile de millepertuis destinée à être utilisée dans le traitement et la cicatrisation de lésions externes telles que des plaies et des brûlures. Ladite invention est un extrait de Hypericum perforatum (millepertuis) dans de l'huile, ladite huile comprenant une certaine quantité d'huile de moelle osseuse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2022019453 | 2022-12-15 | ||
TR2022/019453 | 2022-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024129048A1 true WO2024129048A1 (fr) | 2024-06-20 |
Family
ID=91485556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2023/051557 WO2024129048A1 (fr) | 2022-12-15 | 2023-12-15 | Composition synergique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024129048A1 (fr) |
-
2023
- 2023-12-15 WO PCT/TR2023/051557 patent/WO2024129048A1/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8668944B2 (en) | Topical oil for treating physical ailments and method for making and applying the same | |
US20190008906A1 (en) | Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases | |
US20190151232A1 (en) | Topical Compositions, Process of Manufacture and Method of Use | |
CN108653013A (zh) | 一种植物保湿水润晒后修复霜及其制备方法 | |
EP2364713B1 (fr) | Composition dermatologique à utiliser dans le traitement des brûlures de la peau, maladies de la peau et plaies infectées | |
US11564963B2 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
KR101930264B1 (ko) | 현호색, 캣츠클로, 센티드제라늄, 아그리모니, 인동덩굴, 개박하 및 솔잣나무 복합추출물을 유효성분으로 함유하는 피지생성 억제 및 여드름 개선용 화장료 조성물 | |
KR102065395B1 (ko) | 탈모방지용 조성물 | |
WO2017060535A1 (fr) | Formulation topique de cicatrisation à base de plantes | |
EP4153321A1 (fr) | Compositions topiques, procédé de fabrication à grande échelle et méthode d'utilisation | |
HU203668B (en) | Cosmetic containing medicinal plants and process for producing composition against psoriasis | |
WO2024129048A1 (fr) | Composition synergique | |
KR20110139486A (ko) | 꿀 및 봉독을 유효성분으로 함유하는 상처 치유용 피부외용제 조성물 | |
KR101679391B1 (ko) | 피뿌리풀 추출물 또는 그의 분획물을 포함하는 상처를 치료하기 위한 조성물 및 개체의 상처를 치료하는 방법 | |
RU2416425C1 (ru) | Масло противопролежневое | |
RU2314791C1 (ru) | Косметический крем-бальзам для ухода за кожей лица и шеи | |
KR101597762B1 (ko) | 피뿌리뿔 추출물 또는 그의 분획물을 포함하는 상처를 치료하기 위한 조성물 및 개체의 상처를 치료하는 방법 | |
RU2598706C1 (ru) | Способ получения экстракта бобровой струи для производства биологически активной добавки (варианты) | |
RU2625738C1 (ru) | Способ получения интимного пантового крема для женщин | |
WO2020251478A1 (fr) | Pommade pour plaies naturelle | |
RU2326683C2 (ru) | Мазь ранозаживляющая, противовоспалительная | |
DK3013423T3 (en) | COMPOSITION, INCLUDING OLEUM COCTUS URTICAE | |
KR102651344B1 (ko) | 항염, 근육 증강, 관절 건강 및 연골 건강 개선용 식품 조성물 | |
KR20040023122A (ko) | 가시오가피를 주성분으로 하는 조성물 및 그 제조방법 | |
RU2807890C1 (ru) | Гидрофильная композиция для лечения ран различной этиологии на основе сока каланхоэ перистого |